These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 551896)

  • 81. Experimental analysis of antihypertensive properties of S 5984 and its constituents: tertatolol and indapamide.
    Marmo E; Lampa E; Rosatti F; Berrino L; Russo S; Romano AR; Matera C
    Drugs Exp Clin Res; 1985; 11(10):709-15. PubMed ID: 2873980
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Diverse effects of renal denervation on ventricular hypertrophy and blood pressure in DOCA-salt hypertensive rats.
    Cabral AM; Silva IF; Gardioli CR; Mauad H; Vasquez EC
    Braz J Med Biol Res; 1998 Apr; 31(4):587-90. PubMed ID: 9698814
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Multi-centre clinical investigation of indapamide in the United States: a review.
    Vukovich RA; Zisblatt M; Caruso F; Losi M; Barton J; Schotz WE; Webb E; Eff J; Bronstein R; Neiss ES
    Curr Med Res Opin; 1983; 8 Suppl 3():109-22. PubMed ID: 6352183
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.
    Buckingham RE; Hamilton TC; Robson D
    Br J Pharmacol; 1977 Jul; 60(3):461-9. PubMed ID: 19118
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Indapamide. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension.
    Chaffman M; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Sep; 28(3):189-235. PubMed ID: 6489195
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Changes in vascular reactivity in experimental hypertensive animals following treatment with indapamide.
    Finch L; Hicks PE; Moore RA
    J Pharm Pharmacol; 1977 Dec; 29(12):739-43. PubMed ID: 22620
    [No Abstract]   [Full Text] [Related]  

  • 87. Protective effects of delapril, indapamide and their combination chronically administered to stroke-prone spontaneously hypertensive rats fed a high-sodium diet.
    Biagini G; Zoli M; Torri C; Boschi S; Vantaggiato G; Ballestri M; Baraldi A; Agnati LF
    Clin Sci (Lond); 1997 Nov; 93(5):401-11. PubMed ID: 9486085
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Modification of the antihypertensive effect of indapamide by indomethacin.
    Pasnani JS; Gulati OD; Hemavathi KG
    Indian J Physiol Pharmacol; 1989; 33(3):146-50. PubMed ID: 2592038
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
    Suzuki H; Kondo K; Saruta T
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):525-32. PubMed ID: 7270008
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The possible mode of action of indapamide: a review.
    Campbell DB
    Curr Med Res Opin; 1983; 8 Suppl 3():9-24. PubMed ID: 6352188
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The effects of long term oral treatment with indapamide on the development of DOCA-salt hypertension in rats: vascular reactivity studies.
    Hicks PE
    Clin Exp Hypertens (1978); 1979; 1(6):713-31. PubMed ID: 551896
    [TBL] [Abstract][Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.